![Arndt Vogel: I am very excited to be part of the new ESMO Journal ‘ESMO Real World Data and Digital Oncology’ as an associate editor.](https://oncodaily.com/pub/uploads/2023/08/Arndt-Vogel-1-e1691671535612-1280x799.jpeg)
Arndt Vogel: I am very excited to be part of the new ESMO Journal ‘ESMO Real World Data and Digital Oncology’ as an associate editor.
Arndt Vogel, shared a post by Oncology Advance on X/Twitter, adding:
“I am very excited to be part of the new ESMO Journal ‘ESMO Real World Data and Digital Oncology’ as an associate editor.
High-quality RWD will be a great and important contribution to clinical trial data
Looking forward to your manuscripts!”
Quoting Oncology Advance’s post:
“Introducing ESMO Real World Data and Digital Oncology, the latest peer-reviewed open access journal from ESMO.”
For more information click here.
For the video click here.
Sources: Arndt Vogel/Twitter and Oncology Advance/LinkedIn
Arndt Vogel is a managing senior consultant and professor in the Department of Gastroenterology, Hepatology, and Endocrinology at Hannover Medical School. He is the Head of the GI-Cancer Center and of the Center for Personalized Medicine at Medical School Hannover and chairs the Hepatobiliary Cancer Study Group of the AIO, a collaborative group in clinical oncology in Germany. His scientific focus is translational and clinical research in gastrointestinal cancer.